Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic
manifestations. Patients with HCV may develop mixed cryoglobulinemia and its sequelae …

Substantial improvements in the treatment of chronic liver disease have accelerated interest
in uncovering the mechanisms underlying hepatic fibrosis and its resolution. Activation of …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are
increasingly relevant public health issues owing to their close association with the …

Disorders of glucose metabolism, namely glucose intolerance and diabetes, are frequent in
patients with chronic liver diseases. In patients with cirrhosis, diabetes can be either a …

Histological analysis of liver biopsies remains a standard against which other methods of
assessment for the presence and amount of hepatic injury due to nonalcoholic fatty liver …

About 30% of patients with cirrhosis have diabetes mellitus (DM). Nowadays, it is a matter for
debate whether type 2 DM in the absence of obesity and hypertriglyceridemia may be a risk …

Hydroxyvitamin D (25 [OH] D) can potentially interfere with inflammatory response and
fibrogenesis. Its role in disease progression in chronic hepatitis C (CHC) and its relation with …

Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …

Hepatitis C virus (HCV) infection is causally associated with insulin resistance and diabetes
mellitus. This population‐based cohort study aimed to investigate whether antiviral therapy …